These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12480647)

  • 21. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
    Schilling SH
    Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patents and translational research in genomics.
    Kaye J; Hawkins N; Taylor J
    Nat Biotechnol; 2007 Jul; 25(7):739-41. PubMed ID: 17621295
    [No Abstract]   [Full Text] [Related]  

  • 23. Beyond an uninformed public? A comparative analysis of survey data concerning patenting and commodification.
    Outerbridge T
    Health Law Rev; 2003; 11(2):3-7. PubMed ID: 15706696
    [No Abstract]   [Full Text] [Related]  

  • 24. The scope of utility in the twenty-first century: new guidance for gene-related patents.
    Summers TM
    Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
    [No Abstract]   [Full Text] [Related]  

  • 25. Genes, patents, and bioethics -- will history repeat itself?
    Poland SC
    Kennedy Inst Ethics J; 2000 Sep; 10(3):265-81. PubMed ID: 11658212
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioprospecting, genetic patenting and indigenous populations: challenges under a restructured information commons.
    Faye DJ
    J World Intellect Prop; 2004 May; 7(3):401-28. PubMed ID: 16755699
    [No Abstract]   [Full Text] [Related]  

  • 27. Surpassing the material: the human rights implications of informed consent in bioprospecting cells derived from indigenous people groups.
    Wu AO
    Wash Univ Law Q; 2000; 78(3):979-1003. PubMed ID: 16273699
    [No Abstract]   [Full Text] [Related]  

  • 28. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 29. The economics of human gene patents.
    Scherer FM
    Acad Med; 2002 Dec; 77(12 Pt 2):1348-67. PubMed ID: 12480645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nail in the coffin for DNA sequence patents?
    Yamanaka M
    Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072
    [No Abstract]   [Full Text] [Related]  

  • 31. Sharing the benefits of genetic research.
    Schroeder D; Ladikas M; Schuklenk U; Lasén Diáz CL; Kleinsmidt A; Alvarez-Castillo F; Feinholz D
    BMJ; 2005 Dec; 331(7529):1351-2. PubMed ID: 16339223
    [No Abstract]   [Full Text] [Related]  

  • 32. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents.
    Derzko NM; Behringer JW
    Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101
    [No Abstract]   [Full Text] [Related]  

  • 33. India's IP snub.
    Jayaraman KS
    Nat Biotechnol; 2008 Apr; 26(4):362. PubMed ID: 18392000
    [No Abstract]   [Full Text] [Related]  

  • 34. Creating clones, kids & chimera: liberal democratic compromise at the crossroads.
    Adams NA
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):71-149. PubMed ID: 14986647
    [No Abstract]   [Full Text] [Related]  

  • 35. Patenting of genetic material: are the benefits to society being realized?
    Willison DJ; MacLeod SM
    CMAJ; 2002 Aug; 167(3):259-62. PubMed ID: 12186174
    [No Abstract]   [Full Text] [Related]  

  • 36. The two meanings of how and the gene patenting debate.
    Evans JH
    Am J Bioeth; 2002; 2(3):26-8. PubMed ID: 12230851
    [No Abstract]   [Full Text] [Related]  

  • 37. Innovation and patents: in vitro diagnostics.
    Carter S
    Med Device Technol; 2003 May; 14(4):24. PubMed ID: 12774574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic patents: gatekeeper to the promised cures.
    Westin LP
    Thomas Jefferson Law Rev; 2002; 25(1):271-99. PubMed ID: 15164741
    [No Abstract]   [Full Text] [Related]  

  • 39. Minimizing risk in the management of intellectual property.
    Trevett KP; Hart JD; Sullivan CB
    J Healthc Risk Manag; 1993; 13(4):22-8. PubMed ID: 10129558
    [No Abstract]   [Full Text] [Related]  

  • 40. Patents and human genome research in developing countries: problems and proposals.
    Thambisetty S
    J World Intellect Prop; 2002 Sep; 5(5):685-723. PubMed ID: 15986548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.